Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

April W Armstrong

Showing results (321-330 of 522) with videos related to

Pageof 53
Sort By:
Journal of Drugs in Dermatology : JDD|August 9, 2023
Consensus Statements on the Use of Corticosteroid-Containing Topical Medications in PsoriasisApril W Armstrong, Rasika Reddy, Samiya Khan, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|May 5, 2010
Evaluation and comparison of store-and-forward teledermatology applicationsApril W Armstrong, Christopher Sanders, Aron D Farbstein, et al.
Journal of Drugs in Dermatology : JDD|March 11, 2026
Advanced Topical Nonsteroidal Therapies for Atopic Dermatitis: Consensus Statements from an Expert PanelApril W Armstrong, Yvonne Nong, Christopher G Bunick, et al.
The British Journal of Dermatology|February 10, 2023
Psoriasis and fatigue: a cross-sectional population study of psoriasis patients in the United States using the Medical Expenditure Panel SurveysCaterina Zagona-Prizio, Sabrina Khan, Danielle K Yee, et al.
The Journal of Dermatology|June 19, 2025
Do female patients see their physicians differently? A population-based study evaluating perception of physician communication by patients with hidradenitis suppurativaLucy F Harvey, Paige Kingston, Robin Kikuchi, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|October 4, 2023
Atopic Dermatitis and the Risk of Actinic Keratosis Development: A Population-Based StudyMargaret Y Huang, Hannah Peterson, Danielle Yee, et al.
Dermatologic Clinics|September 24, 2021
The Use of Biologics During the COVID-19 PandemicMadison E Jones, Alison H Kucharik, Sarah P Pourali, et al.
Dermatology and Therapy|March 7, 2022
Demographic and Clinical Factors Associated with Patient-Reported Remission in PsoriasisGeorge Gondo, Edward Hadeler, Nicholas Brownstone, et al.
Plos One|October 24, 2025
Chronic companions: An updated national cross-sectional study of metabolic syndrome comorbidities in outpatient visits for hidradenitis suppurativaElaine J Ma, Alyssa M Roberts, Peichi Chou, et al.
American Journal of Clinical Dermatology|September 10, 2020
Maintenance of Response Through up to 4 Years of Continuous Guselkumab Treatment of Psoriasis in the VOYAGE 2 Phase 3 StudyKristian Reich, April W Armstrong, Peter Foley, et al.
Pageof 53

Showing results (321-330 of 522) with videos related to

Sort By:
Pageof 53
Journal of Drugs in Dermatology : JDD|August 9, 2023
Consensus Statements on the Use of Corticosteroid-Containing Topical Medications in PsoriasisApril W Armstrong, Rasika Reddy, Samiya Khan, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|May 5, 2010
Evaluation and comparison of store-and-forward teledermatology applicationsApril W Armstrong, Christopher Sanders, Aron D Farbstein, et al.
Journal of Drugs in Dermatology : JDD|March 11, 2026
Advanced Topical Nonsteroidal Therapies for Atopic Dermatitis: Consensus Statements from an Expert PanelApril W Armstrong, Yvonne Nong, Christopher G Bunick, et al.
The British Journal of Dermatology|February 10, 2023
Psoriasis and fatigue: a cross-sectional population study of psoriasis patients in the United States using the Medical Expenditure Panel SurveysCaterina Zagona-Prizio, Sabrina Khan, Danielle K Yee, et al.
The Journal of Dermatology|June 19, 2025
Do female patients see their physicians differently? A population-based study evaluating perception of physician communication by patients with hidradenitis suppurativaLucy F Harvey, Paige Kingston, Robin Kikuchi, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|October 4, 2023
Atopic Dermatitis and the Risk of Actinic Keratosis Development: A Population-Based StudyMargaret Y Huang, Hannah Peterson, Danielle Yee, et al.
Dermatologic Clinics|September 24, 2021
The Use of Biologics During the COVID-19 PandemicMadison E Jones, Alison H Kucharik, Sarah P Pourali, et al.
Dermatology and Therapy|March 7, 2022
Demographic and Clinical Factors Associated with Patient-Reported Remission in PsoriasisGeorge Gondo, Edward Hadeler, Nicholas Brownstone, et al.
Plos One|October 24, 2025
Chronic companions: An updated national cross-sectional study of metabolic syndrome comorbidities in outpatient visits for hidradenitis suppurativaElaine J Ma, Alyssa M Roberts, Peichi Chou, et al.
American Journal of Clinical Dermatology|September 10, 2020
Maintenance of Response Through up to 4 Years of Continuous Guselkumab Treatment of Psoriasis in the VOYAGE 2 Phase 3 StudyKristian Reich, April W Armstrong, Peter Foley, et al.
Pageof 53